Clinical Trial Update: Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase 1/2 trial evaluated the safety and immune response of a Hepatitis B vaccine given with a CpG7909 ODN booster in adults with and without HIV…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B

Drugs mentioned

• CpG7909 ODN booster (CpG7909 oligodeoxynucleotide booster)
• Hepatitis B vaccine (Hepatitis B vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Hepatitis B | Phase 1, Phase 2 | Status: COMPLETED